Cargando…
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
The rapid scale-up of research on coronavirus disease 2019 (COVID-19) has spawned a large number of potential vaccines and immunotherapies, accompanied by a commensurately large number of in vitro assays and in vivo models to measure their effectiveness. These assays broadly have the same end-goal —...
Autores principales: | Khoury, David S., Wheatley, Adam K., Ramuta, Mitchell D., Reynaldi, Arnold, Cromer, Deborah, Subbarao, Kanta, O’Connor, David H., Kent, Stephen J., Davenport, Miles P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605490/ https://www.ncbi.nlm.nih.gov/pubmed/33139888 http://dx.doi.org/10.1038/s41577-020-00471-1 |
Ejemplares similares
-
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021) -
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022) -
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023) -
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022) -
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)